The extent of implementation of the agenda will be determined through surveys and networking events, which will provide opportunities to capitalize on funding and partnership opportunities to conduct research. The ultimate goal of the Agenda is to improve patient care and EMS system delivery through the creation and use of meaningful and high quality EMS research. Possible benchmarks include grant funding acquired, publications, clinical outcomes (such as changes in survival), cost savings, and the number of Inhibitors,research,lifescience,medical EMS systems actively involved in research.
Discussion In this comprehensive mixed methods study, we anticipate the keys to success will be: 1) ensuring a representative sample of EMS stakeholders, 2) fostering an open and collaborative roundtable discussion, and 3) adhering to a predefined approach Inhibitors,research,lifescience,medical to measure consensus
on each topic. Steps have been taken in the methodology to address each of these a priori concerns. The findings of this study will provide leaders in EMS administration, regulation, medical Inhibitors,research,lifescience,medical direction, academia, clinical practice, government funding agencies, foundations and industrial partners with critical evidence to further strengthen Canadian EMS research. Abbreviations EMS: emergency medical services Competing interests JLJ and AC receive salary support from Emergency Health Services to conduct EMS research. IEB receives salary support from this website Alberta Health Services – EMS to conduct EMS research. EC receives salary support from Dalhousie University to direct and conduct EMS research. AMC receives salary support from the City of Toronto to conduct research and has received travel support from ZOLL Medical. KND receives Inhibitors,research,lifescience,medical salary support to conduct research from grant funding. LJM is an investigator with the Resuscitation Outcomes Consortium (ROC). ZOLL Medical Inc, Phillips and Medtronic have a partnership agreement with
the NIH, which sponsors ROC. Their agreement pertains to the provision of equipment and software to the participating Inhibitors,research,lifescience,medical EMS and Fire Services. A portion of LJM’s salary support is provided by the NIH Grant that supports the U of T ROC Regional Coordinating full read Centre. LJM holds grants from Canadian Institute of Health Research, Heart and Stroke Foundation Canada, American Heart Association, Laerdal Medical Foundation and the Ontario Ministry of Health. No other author has a financial or academic conflict of interest Dacomitinib to disclose in regard to this study topic. Authors’ contributions JLJ, IEB, BLB and DS developed the research concept and plan. JLJ and KD obtained research ethics approval. JLJ, IEB, BLB, DS obtained funding. JLJ, IEB, BLB, DS, KD and RB recruited and enrolled participants. All authors contributed substantially to the design and methodology of this study and to the writing and critical editing of this manuscript, and intend to remain significantly involved in the study until completion.